VistaGen Therapeutics
VTGN
VTGN
104 hedge funds and large institutions have $360M invested in VistaGen Therapeutics in 2021 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 35 increasing their positions, 29 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
7% less capital invested
Capital invested by funds: $387M → $360M (-$26.5M)
93% less call options, than puts
Call options by funds: $50K | Put options by funds: $704K
Holders
104
Holding in Top 10
2
Calls
$50K
Puts
$704K
Top Buyers
| 1 | +$13.1M | |
| 2 | +$4.91M | |
| 3 | +$2.85M | |
| 4 |
EGI
EAM Global Investors
Solana Beach,
California
|
+$1.74M |
| 5 |
Two Sigma Advisers
New York
|
+$1.31M |
Top Sellers
| 1 | -$4.27M | |
| 2 | -$866K | |
| 3 | -$701K | |
| 4 |
SB
Samsara BioCapital
Palo Alto,
California
|
-$669K |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$524K |